Contact Us

Depomed Headquarters
7999 Gateway Blvd., Suite 300
Newark, CA 94560
Tel: 510.744.8000
Fax: 510.744.8001

Investor Relations 
investors@depomed.com

Business Development
busdev@depomed.com

Trade
trade@depomed.com

Managed Care
managedmarkets@depomed.com

Patient/ Physician Information

Phone Number: 866.458.6389
Email Address: depomed@ashfieldhealthcare.com

Gralise® (gabapentin) Tablets, for the management of post-herpetic neuralgia (PHN)
Product website: www.gralise.com

Cambia® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory (NSAID) drug for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older
Product website: www.CambiaRx.com

Zipsor® (diclofenac potassium) Liquid filled capsules, for the relief of mild to moderate acute pain in adults
Product website: www.zipsor.com

Lazanda® (fentanyl) nasal spray CII, for the management of breakthrough pain in cancer patients
Product website: www.lazanda.com

 

Key Facts

Headquarters: Newark, CA

Nasdaq symbol: DEPO

Number of employees: Approx. 325

Marketed Products:

Gralise® (gabapentin) tablets for the management of Postherpetic Neuralgia (PHN)

Cambia® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory (NSAID) drug for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older.

Zipsor® (diclofenac potassium) liquid filled capsules for relief of mild to moderate acute pain

Lazanda® (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients

Addressing Important Markets

Postherpetic Neuralgia

Mild to Moderate Acute Pain

Breakthrough Pain in Cancer Patients

Migraine

Products Marketed By Partners

Glumetza® (metformin hydrochloride extended-release tablets) by Santarus

Janumet® XR (sitagliptin/metformin HCl extended-release) tablets by Merck

Nucynta® ER (tapentadol) extended-release oral tablets by Janssen